Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTelegram groups advertising Mounjaro without a prescription are selling a counterfeit risk, not a clinical service. Mounjaro (tirzepatide) is a Prescription-Only Medicine in the UK: a GPhC-registered prescriber must assess you before any pen can legally be dispensed. No Telegram channel changes that. If you have seen these groups and are wondering whether they offer a legitimate route to tirzepatide, the honest answer is no — and the risks of grey-market tirzepatide sourced through Telegram are serious enough that the MHRA has made them a specific enforcement priority.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people who find these groups assume the sellers are buying genuine stock in bulk (perhaps from a country where tirzepatide is cheaper) and passing savings on. It is a reasonable thing to assume, and it is almost entirely wrong. The MHRA's enforcement operation through 2024 and 2025 found counterfeit pens produced domestically, including a manufacturing site in Northampton raided in October 2025. These were not genuine pens purchased abroad. They were fakes, made locally, filled with unknown substances. Some seized pens elsewhere in the UK have tested positive for insulin, a medicine that, injected into someone without diabetes, can cause life-threatening hypoglycaemia.
The misconception is understandable. These channels often look professional: branded imagery, reviews, tracking numbers, even customer service chats. That presentation is part of how they operate. The MHRA warns specifically that counterfeit weight-loss products are frequently marketed to appear credible. You can read the regulator's guidance on reporting suspect sellers via the Yellow Card scheme, that is the practical step if you encounter one of these channels.
The supply chain for genuine Mounjaro runs through Eli Lilly's authorised UK distributors, to GPhC-registered pharmacies, dispensed against prescriptions issued by registered prescribers. There is no parallel route through a messaging app.
Tirzepatide is not suitable for everyone. A prescriber reviewing your consultation will check your BMI, your weight-related health conditions, your current medicines, and your medical history before approving treatment. That clinical review is not a formality. Certain conditions (a history of pancreatitis, medullary thyroid carcinoma, or specific gastrointestinal disorders) are reasons a prescriber may not prescribe tirzepatide at all. Other medicines can interact with it in ways that affect absorption. A Telegram seller does none of this. You receive a pen with no clinical oversight, no follow-up, and no verified knowledge of what is inside it.
There is also the question of dosing. Mounjaro starts at 2.5mg, a dose whose job is to let your body adjust, not to produce rapid weight loss. People who source pens informally sometimes start at higher doses, reasoning that more is better. That logic increases the risk of severe gastrointestinal side effects and is done without a prescriber monitoring progress. A genuine programme works differently: the structured Mounjaro programme at a regulated service builds dose increases on clinical evidence of how you are responding. That structure is not bureaucracy. It is what makes the treatment safe and effective.
For a factual grounding in what the medicine is and how it works, the NHS tirzepatide medicines page is the clearest starting point.
The GPhC register is the definitive check. Every UK pharmacy dispensing prescription medicines must be registered, and you can search by name, address or registration number at pharmacyregulation.org/registers. If a seller cannot point you to a GPhC registration number you can verify there, they are not a registered pharmacy. Full stop.
Red flags beyond the absence of a GPhC number: no requirement for a prescription or clinical consultation before purchase; prices substantially below the current private market range (reported to be roughly £149–£375 per month depending on dose and provider since Eli Lilly's UK list price changes in September 2025); payment via cryptocurrency or bank transfer only; no UK returns address; urgency messaging. A Telegram group will typically show several of these at once.
If you want to understand how private pricing for Mounjaro actually works, the Mounjaro pricing guide sets out what legitimate costs cover and why the prescription and clinical review are part of what you are paying for, not optional extras that a clever purchase can skip.
Getting Mounjaro through a regulated UK service is not complicated. A prescriber reads your consultation and, if you are clinically suitable, a GPhC-registered pharmacy dispenses genuine tirzepatide from the licensed supply chain. At nume (sorry, at a service like a clinician-led UK pharmacy) that review happens the same day, by a real prescriber, not software. Pens arrive the next working day in plain packaging via tracked delivery.
Eligibility broadly follows the licensed criteria: adults with a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. The prescriber considers the full picture, not just a number. If you are curious whether tirzepatide is appropriate for you, the tirzepatide overview covers the medicine in detail, and you can also browse the range of weight-loss treatment options to understand how the different medicines compare before speaking to anyone.
Telegram groups persist because demand for tirzepatide outpaces NHS supply and private costs are real. That tension is understandable. But for a prescription medicine, the clinical assessment is not a hurdle to route around, it is the part that keeps you safe. When you are ready to explore a legitimate route, you can check your eligibility with our clinical team at no charge, and if you have already started treatment and want reassurance about your technique, our guide on how to tell if your Mounjaro injection went in correctly is worth a read.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.